Skip to main content
Equibles

RX · BioSyent Inc.

Use RX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
16.8500 CAD -0.2000 (-1.17%) At close · Nov 3 Intraday price with Plus
Rebalance outlook locked
Market Cap
190.39M CAD
Shares
11.23M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close16.8500 CAD Open17.0500 CAD Day16.8500–17.1000 CAD 52W close10.7100–17.4900 CAD Avg vol 30d7K DataJan 2020–Nov 2026

Latest documents

2026
Aug 20
Report SEDAR+
MD&A
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 10.7100 CAD Now 16.8500 CAD · 91% Range high 17.4900 CAD
vs 200-day avg +13% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XTSX:RX +1.0% +0.7% +15.4% -1.4% +32.4%

Exchange listing

Market
XTSX
Ticker
RX
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company

Website
https://www.biosyent.com/

Other listings of this company

No other verified listings are available.

Latest price

Plus & Pro

Follow RX during the session: the latest price, the day's change, range and volume. Closing prices stay free.

View plans Sign in

Recent dividends

Ex-dividend dateAmount per share
2026-08-310.0550 CAD
2026-05-290.0550 CAD
2026-02-270.0550 CAD
2025-11-280.0500 CAD
2025-08-290.0500 CAD
2025-05-300.0500 CAD
2025-02-280.0500 CAD
2024-11-290.0450 CAD
2024-09-040.0450 CAD
2024-05-310.0450 CAD
2024-02-280.0450 CAD
2023-11-290.0400 CAD
2023-08-300.0400 CAD
2023-06-010.0400 CAD
2023-02-270.0400 CAD
2022-11-290.0400 CAD

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.